14.00Open14.00Pre Close0 Volume2 Open Interest64.00Strike Price0.00Turnover103.99%IV2.08%PremiumDec 20, 2024Expiry Date12.41Intrinsic Value100Multiplier3DDays to Expiry1.59Extrinsic Value100Contract SizeAmericanOptions Type0.9644Delta0.0101Gamma6.09Leverage Ratio-0.0801Theta0.0058Rho5.87Eff Leverage0.0058Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet